与索拉非尼相关的穿通性毛囊炎样反应 - Suppr

Suppr

超能文献

Perforating folliculitis-like reaction related to sorafenib.

作者信息

Eberst Eleonore, Rigau Valérie, Pageaux Georges-Philippe, Guillot Bernard, Kluger Nicolas

机构信息

Skin and Allergy Hospital, HUS, PO Box 160, Helsinki, Finland 00029.

出版信息

Cutis. 2014 Jan;93(1):E8-10.

PMID:24505595

Abstract

摘要

相似文献

Perforating folliculitis-like reaction related to sorafenib.

Cutis. 2014 Jan;93(1):E8-10.

Delayed onset perforating folliculitis associated with sorafenib.

Australas J Dermatol. 2014 Aug;55(3):233-5. doi: 10.1111/ajd.12207.

Sorafenib induced eruptive melanocytic lesions.

Dermatol Online J. 2013 May 15;19(5):18184.

Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib.

Clin Exp Dermatol. 2014 Mar;39(2):232-3. doi: 10.1111/ced.12257. Epub 2013 Dec 12.

Sorafenib in patients with refractory or recurrent multiple myeloma.

Hematol Oncol. 2013 Dec;31(4):197-200. doi: 10.1002/hon.2043. Epub 2013 Mar 15.

Learning from 7 Years of Experience with Sorafenib in Advanced HCC: Sorafenib Better than Sorafenib?

Target Oncol. 2016 Aug;11(4):565-7. doi: 10.1007/s11523-016-0427-8.

Treatment of intermediate-stage hepatocellular carcinoma.

Clin Adv Hematol Oncol. 2015 Aug;13(8):501-3.

A Case of Perforating Folliculitis Induced by Vemurafenib.

Acta Derm Venereol. 2019 Feb 1;99(2):230-231. doi: 10.2340/00015555-3059.

Sorafenib-induced annular pustular psoriasis (Milian-Katchoura type).

Eur J Dermatol. 2013 Nov-Dec;23(6):900-1. doi: 10.1684/ejd.2013.2184.

The adverse effects of sorafenib in patients with advanced cancers.

Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):216-21. doi: 10.1111/bcpt.12365. Epub 2015 Jan 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Perforating folliculitis-like reaction related to sorafenib.

Cutis. 2014 Jan;93(1):E8-10.

Delayed onset perforating folliculitis associated with sorafenib.

Australas J Dermatol. 2014 Aug;55(3):233-5. doi: 10.1111/ajd.12207.

Sorafenib induced eruptive melanocytic lesions.

Dermatol Online J. 2013 May 15;19(5):18184.

Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib.

Clin Exp Dermatol. 2014 Mar;39(2):232-3. doi: 10.1111/ced.12257. Epub 2013 Dec 12.

Sorafenib in patients with refractory or recurrent multiple myeloma.

Hematol Oncol. 2013 Dec;31(4):197-200. doi: 10.1002/hon.2043. Epub 2013 Mar 15.

Learning from 7 Years of Experience with Sorafenib in Advanced HCC: Sorafenib Better than Sorafenib?

Target Oncol. 2016 Aug;11(4):565-7. doi: 10.1007/s11523-016-0427-8.

Treatment of intermediate-stage hepatocellular carcinoma.

Clin Adv Hematol Oncol. 2015 Aug;13(8):501-3.

A Case of Perforating Folliculitis Induced by Vemurafenib.

Acta Derm Venereol. 2019 Feb 1;99(2):230-231. doi: 10.2340/00015555-3059.

Sorafenib-induced annular pustular psoriasis (Milian-Katchoura type).

Eur J Dermatol. 2013 Nov-Dec;23(6):900-1. doi: 10.1684/ejd.2013.2184.

The adverse effects of sorafenib in patients with advanced cancers.

Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):216-21. doi: 10.1111/bcpt.12365. Epub 2015 Jan 14.